警惕以稳定币为名的犯罪活动 警惕以稳定币等名义实施非法集资。 7月7日，深圳市防范和打击非法金融活动专责小组办公室（"专责小组"）就稳定币涉及的相关风险发出风 险提示。 在提示中，专责小组表示，近期以稳定币为代表的数字货币受到市场广泛关注。但监测发现，一些不法机 构以"金融创新""数字资产"等为噱头，利用社会公众对稳定币等了解不足的特点，通过发行所谓"虚拟货 币""虚拟资产""数字资产"等方式吸收资金，诱导社会公众参与交易炒作，扰乱经济金融秩序，滋生非法集 资、赌博、诈骗、传销、洗钱等违法犯罪活动，严重危害社会公众财产安全。 专责小组表示，此类不法机构未经国家金融管理部门依法许可或者违反国家金融管理规定，不具有公开吸 收公众存款的资质。该类机构利用稳定币等新概念进行炒作，编造所谓的"虚拟货币""虚拟资产""数字资 产"等投资项目，公开虚假宣传并吸收公众资金，滋生非法集资、赌博、诈骗、传销、洗钱等违法犯罪活 动。专责小组强调，《防范和处置非法集资条例》规定，国家禁止任何形式的非法集资，因参与非法集资 受到的损失，由集资参与人自行承担。请广大群众增强理性投资意识，不要盲目相信天花乱坠的承诺，树 立正确的货币观念和 ...

巴黎大区工商会会长Dominique Restino在欢迎辞中表示："在价值链重组、可持续发展挑战加剧、经济主权日益受到重视等诸多快速变革下，法中关 系正开启全新篇章。法国企业亟须顺应时代变局，而中国是诸多领域至关重要的战略要地，也是法国企业的重要市场——对法国优势产业企业而言更 是如此。" 第十一届中欧"欧洲论坛"现场。 2025年正值中欧建交50周年重要节点，中法两国作为东西方文明对话的典范，正以开放为锚点，深化战略协同，探索重塑增长的重心。本次论坛 以"不确定时代：开放重塑增长"为主题，特邀中法两国政商学界重磅嘉宾共同探讨两国如何实现优势互补、双方产业如何在不确定时代实现可持续增 长等关键议题。 新京报贝壳财经讯（记者丁爽）"在地缘政治和全球经济充满不确定性的时代，唯有'开放'才能在不确定中创造确定性。时值中欧建交50周年之际， 中国和欧洲作为全球两大力量、两大市场、两大文明，可为当前不确定性的时代注入更多的确定性。"6月30日，第十一届中欧国际工商学院"欧洲论 坛"在巴黎举办，论坛致辞环节，中欧国际工商学院院长汪泓表示。 法国前外交部长于贝尔·韦德里纳（Hubert Vedrine）则在主旨演讲中指出 ...

证券时报记者陈霞昌 香港特别行政区《稳定币条例》将于8月1日生效，届时香港金融管理局（以下简称"金管局"）将开始接 受牌照申请。目前，金管局正就落实条例的具体指引进行市场咨询，争取尽快订立指引。金管局总裁余 伟文表示，初期稳定币牌照的发放数量有限，希望市场能够客观冷静对待近期高涨的稳定币情绪。 由于预期稳定币将被更广泛地使用，如何妥善管控各种内在和外溢风险正逐渐成为国际监管的焦点。 余伟文强调，金管局一直积极参与国际监管组织的工作，当中包括二十国集团（G20）辖下金融稳定理 事会（FSB）在2023年发布的《全球加密资产活动监管框架》。框架就如何监管稳定币提供了一套指导 性的国际准则，而香港的监管制度基本上就是以此为蓝本。 余伟文还透露，目前金管局正牵头FSB对上述框架在全球各地实施情况的检讨工作。稳定币是相对新兴 的金融工具，既具有传统金融工具的属性，也有其特殊之处，例如其匿名和便于跨境使用的特性，带来 了管控风险特别是反洗钱方面的挑战。因此，在国际层面互相借鉴监管措施和交换经验，并借此逐步建 立跨境监管合作，有助于营造一个利于稳定币在全球范围健康有序发展、降低金融风险的环境。 在稳定币发行人发牌制度方面， ...

Group 1 - The forum focused on the theme "Uncertain Times: Open Reshaping Growth," emphasizing that only "openness" can create certainty amid uncertainty in geopolitics and the global economy [1] - The relationship between China and France is entering a new chapter, with France recognizing China as a crucial strategic market across various sectors [1][2] - The bilateral trade and investment between China and France have achieved fruitful results over the past 50 years, contributing to a mutually beneficial community [2] Group 2 - The first roundtable discussion highlighted opportunities in the "China-France Health Industry," noting the rapid development of China's medical innovation and the potential for effective cooperation [3] - The second roundtable focused on the "Growth Drivers of the China-France Consumer Market," with LVMH's Secretary General emphasizing the strategic value of the Chinese market for European luxury goods, as 10% of LVMH's 215,000 employees work in China [3]

新东方上涨8.85%，恒隆地产涨8.79%，金沙中国有限公司涨5.99%，领涨蓝筹。 | 序号 | 名称 | 代码 | 现价 | 涨跌 | 涨跌幅 ▼ | 成交额 | 年初至今 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 新东方-S | 9901 | 44.300 c | 3.600 | 8.85% | 8.76亿 | -9.50% | | 2 | 恒隆地产 | 0101 | 7.550 c | 0.610 | 8.79% | 3.05亿 | 29.20% | | 3 | 金沙中国有限公司 | 1928 | 16.640 c | 0.940 | 5.99% | 5.65亿 | -19.07% | | 4 | 中芯国际 | 0981 | 44.050 c | 2.350 | 5.64% | 71.67亿 | 38.52% | | ਦੇ | 恒基地产 | 0012 | 28.750 c | 1.250 | 4.55% | 2.47亿 | 28.63% | | 6 | 中国海外发展 | 0688 | 14.040 c | 0.480 | 3.5 ...

香港特别行政区《稳定币条例》将于8月1日生效，届时香港金融管理局（以下简称"金管局"）将开始接受牌照 申请。目前，金管局正就落实条例的具体指引进行市场咨询，争取尽快订立指引。金管局总裁余伟文表示，初 期稳定币牌照的发放数量有限，希望市场能够客观冷静对待近期高涨的稳定币情绪。 香港预期在初始阶段只会批出数个牌照。 对于市场关心的稳定币牌照数量问题，余伟文也作出了回应。他表示，考虑到稳定币是相对新兴的产物、发行 业务所涉及的风险、对用户的保障，以及市场的承载力和长远发展，牌照发放设有相当高的门槛，香港预期在 初始阶段只会批出数个牌照。获发牌的稳定币发行人必须有实实在在的应用场景，以稳健和可持续的方式营运 业务。 金管局在去年年初推出稳定币发行人"沙盒"，旨在了解计划在香港发行法币稳定币的机构的业务模式，并传达 监管预期及提供指引。但余伟文强调，一方面，进入"沙盒"并非将来申请稳定币发行人牌照的先决条件；另一 方面，即使已进入"沙盒"的参与机构，亦不表示必然会获得牌照。金管局将按照一致、严格的标准，审慎考虑 所有牌照申请。 责编：李丹 校对：王蔚 "作为稳定币监管制度的执行者，我们固然乐见公众对稳定币产生兴趣，但出 ...

美国与瑞士打破了在客户投资信息共享问题上持续数年的僵局。 当地时间6月10日，美国证券交易委员会（SEC）宣布，将立即恢复处理瑞士注册投资顾问（RIA）的 申请，终结自2020年因监管数据争议导致的审批暂停。 在该公告发布前，SEC与瑞士金融市场监督管理局（FINMA）就关键监管合作达成一致：受FINMA监 管且在SEC注册的瑞士投资顾问，可直接向SEC提供包含个人数据的账簿记录；同时SEC可在符合美瑞 两国法律框架下，对瑞士境内相关机构开展现场检查。 美瑞两国在涉及美国客户金融信息的议题上，长期存在复杂的监管博弈。外界认为，这一举措为瑞士金 融机构打开美国财富管理市场大门，同时为SEC获取瑞士境内客户资产信息铺平了道路。 监管博弈 SEC主席保罗·阿特金斯（Paul S. Atkins）表示："重启瑞士RIA审批进程刻不容缓，我们期待扩大美国资 本市场的准入机会。" 2020年，SEC暂停了处理瑞士投资顾问提交的RIA申请。SEC一方面担忧瑞士本地RIA无法有效提供其 所需的数据，另一方面顾虑自身对瑞士金融机构开展现场检查的实际执行能力受限。 这一系列监管行动促使瑞士银行业摒弃传统 "绝对保密"的运营模式， ...

Core Viewpoint - The meeting between the Deputy Director of the National Financial Supervision Administration of China and the Director of the Insurance Regulatory Authority of the Democratic Republic of the Congo focused on enhancing insurance market development and regulatory cooperation between the two countries [1] Group 1: Regulatory Cooperation - A memorandum of understanding was signed to strengthen insurance regulatory cooperation between China and the Democratic Republic of the Congo [1] - The discussions were aimed at implementing the consensus reached during the China-Africa Cooperation Forum Summit [1]

Core Viewpoint - The China Securities Regulatory Commission (CSRC) aims to enhance transparency and predictability in its systems, improve communication with international investors, and optimize the management of overseas listings and qualified foreign institutional investors [1] Group 1: Regulatory Enhancements - The CSRC will focus on improving the quality and efficiency of overseas listing filing management [1] - There will be support for qualified foreign institutions to apply for new businesses and establish new products [1] - The cross-border financial service system will be continuously improved [1] Group 2: Market Opening and Coordination - The CSRC will enhance the systematic nature of opening up, coordinating the opening of stock, bond, and futures markets [1] - There will be an increase in the supply of internationalized futures and options products [1] - The aim is to enrich asset allocation and risk management tools [1] Group 3: International Cooperation - The CSRC will strengthen bilateral and multilateral cross-border regulatory cooperation [1] - Active participation in the formulation of international standards and rules will be emphasized [1] - The collaboration between the mainland and Hong Kong markets will be further strengthened to consolidate Hong Kong's status as an international financial center [1]

Group 1: Positive Factors - The advancement of Sino-U.S. regulatory cooperation has alleviated the delisting risks for Chinese companies listed in the U.S. [2] - The Federal Reserve's interest rate cuts in 2024 are expected to enhance market liquidity, leading to a projected 116% year-on-year increase in fundraising for Chinese companies going public in the U.S. [3] - Specific industries such as biomedicine and hard technology are likely to benefit from U.S. market valuations that recognize innovation and high R&D investments [4] - The internationalization demand in sectors like new energy and autonomous driving has led to significant brand effects for companies like Zeekr and WeRide after their U.S. listings [5] - The U.S. has a more accommodating stance towards cryptocurrency companies, attracting Chinese firms to split their businesses and list in the U.S. [6] - New policies in China support the expansion of overseas listing channels, with the China Securities Regulatory Commission (CSRC) optimizing the filing process, resulting in a significant increase in the number of companies preparing for listings in 2024 [7] Group 2: Major Challenges - Geopolitical tensions and regulatory conflicts remain a concern, particularly with the U.S. Foreign Company Accountability Act posing potential delisting risks if Sino-U.S. audit cooperation falters [8] - Compliance pressures from China's Data Security Law require companies to separate sensitive operations or localize data storage, increasing listing costs [9] - Market performance is uneven, with over two-thirds of Chinese companies listed in the U.S. in 2024 experiencing stock price declines, while smaller firms face high issuance costs that diminish fundraising efficiency [10] - The Hong Kong Stock Exchange has lowered listing thresholds for specialized technology companies, creating competition for Chinese firms considering dual listings [11] - The A-share Sci-Tech Innovation Board is prioritizing hard technology companies, which may lead to local financing preferences [12] - Nasdaq's new rules set to be implemented by the end of 2024 will increase the difficulty for small and medium-sized enterprises to meet market capitalization requirements for IPOs [13] Group 3: Future Outlook - An optimistic scenario suggests that if Sino-U.S. regulatory cooperation deepens and the Federal Reserve continues to lower interest rates, leading tech and biomedicine companies could see a 20%-30% year-on-year increase in IPO fundraising [14][15] - A neutral scenario indicates that if regulatory deadlocks persist but geopolitical tensions remain manageable, a few companies may pursue dual listings or split non-sensitive operations for U.S. entry, resulting in moderate fundraising growth [16][17] - A pessimistic scenario predicts that if the Sino-U.S. tech conflict escalates and China tightens overseas listing approvals, IPO activities in the U.S. could nearly halt, accelerating the privatization of existing Chinese companies listed abroad [18][19] Group 4: Corporate Strategy Recommendations - Companies are advised to prioritize compliance by designing cross-border data and legal frameworks, such as VIE structures and independent data entities [20] - Diversifying financing strategies through a combination of A-share/H-share and U.S. listings can help mitigate risks [21] - Companies in hard technology should focus on local listings, while those with strong global attributes, like biomedicine, should target U.S. markets [22]